Pioneering for Patients

About Galapagos

We are a fully integrated biotechnology company focused on discovering, developing, and commercializing innovative medicines. We are committed to improving patients’ lives worldwide by targeting diseases with high unmet needs. 

On track to become a leading European biotech


years of ground-breaking research and development with a first medicine on the market


year partnership signed with Gilead in 2019

An increasing global reach


employees globally


      sites across Europe and the US

Innovative science to address patient needs is at the heart of our business


of employees work in R&D


of employees work in commercial

Targeting a range of conditions, including these underserved diseases



Our Mission

Our focus and commitment to patients will always remain at the center of everything we do with the aim to add years of life and quality of life of patients across the globe.

Our R&D capabilities cover multiple drug modalities, including small molecules and cell therapies. Our portfolio comprises discovery through to Phase 4 programs in immunology, oncology, and other indications.Our first medicine for rheumatoid arthritis and ulcerative colitis is available in Europe and Japan.

For additional information, please visit or follow us on LinkedIn or Twitter


Clinical Trials

Galapagos conducts Phase 1 trials in healthy volunteers in centers which are specifically equipped for this purpose, with the aim to test the safety, tolerability and …


We’re not only looking for scientists. We’re looking for pioneers in a wide range of domains: The best-in-class doctors, …

Corporate Responsibility

Our commitment to Corporate Social Responsibility (CSR) is intrinsically linked to our core mission: to discover and develop …